This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
EMEA approval process questioned
Malaria drug possibilities unveiled
Study reveals new statin risks
Study evaluates efficiacy of INTUNIV
Ozurdex receives positive opinion from CHMP for treatment of macular oedema
Maintenance therapy’ with rituximab doubles chance of sustaining remission
Nexavar data to be presented at American Society of Clinical Oncology
Boehringer present new oncology data
Asda to sell cancer drugs at cost
Mental health approach questioned
FDA mulls enhanced drug disclosure
NicOx’s shareholder meetings
« Previous
1
…
66
67
68
69
70
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: